C

Carmine Therapeutics

32 employees

Carmine Therapeutics develops a novel type of gene therapy that utilizes extracellular vesicles produced in the laboratory.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Therapeutics
Biotech
Rare diseases
Red blood cell extracellular vesicles
Platform technologies
Health Care
Non-viral gene therapy

Date founded

2019

Funding rounds raised

Total raised

$3.4M

from 2 investors over 2 rounds

C

Carmine Therapeutics raised undisclosed on October 13, 2022

Investors: 华盖资本有限责任公司

C

Carmine Therapeutics raised $3.4M on August 29, 2019

Investors: Esco Ventures X

FAQ